“High Flow Therapy and Non-Invasive Ventilation in COVID-19 Patients”
Event Navigation
Saxe Healthcare Communications and Phillips* present…“High Flow Therapy and Non-Invasive Ventilation in COVID-19 Patients”
The initial fear of COVID-19 transmission to healthcare workers resulted in many choosing to avoid the use of HFNC or NIV therapy in these patients. Most of the concerns were not supported by evidence, rather lack of evidence. This presentation will discuss the use of HFNC and NIV therapy in COVID-19 patients, and present supportive data for its use, while providing suggested parameters important for monitoring success or failure of therapy.
Learning Objectives | At the end of this educational activity, participants should be able to:
- Discuss the initial concerns of HFNC and NIV use in COVID-19 associated respiratory failure
- Describe what evidence exists for non-COVID-19 respiratory failure support with HFNC and NIV
- Explain clinical concepts related to using HFNC and NIV in COVID-19 patients in respiratory failure
Presenter:
Thomas Piraino, RRT, FCSRT, FAARC | Clinical Specialist & Research Collaborator | St. Michael’s Hospital Centre of Excellence | Registered Respiratory Therapist | Kingston General Hospital Ontario | Lecturer (Adjunct) for the Department of Anesthesia, Division of Critical Care at McMaster University
Continuing Education for Nurses and Respiratory Therapists. Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care. This education activity is approved for 1.0 contact hour. Provider Saxe Healthcare Communications approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.
Educational support provided by Philips.
Questions should be directed to Saxe Communications: 561-805-5784 | sshapiro@saxecommunications.com
* NOTE: This is a supplier and industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
